Jillian R Tate

Summary

Country: Australia

Publications

  1. ncbi The determination of the 99th centile level for troponin assays in an Australian reference population
    Jillian R Tate
    Chemical Pathology Department, Pathology Queensland, Royal Brisbane and Women s Hospital, Herston, QLD 4029, Australia
    Ann Clin Biochem 45:275-88. 2008
  2. ncbi Recommendations for standardized reporting of protein electrophoresis in Australia and New Zealand
    Jillian Tate
    Chemical Pathology Department, Pathology Queensland, Royal Brisbane and Women s Hospital, Herston Road, Brisbane, Queensland 4029, Australia
    Ann Clin Biochem 49:242-56. 2012
  3. ncbi Standardisation of cardiac troponin I measurement: past and present
    Jillian R Tate
    Pathology Queensland, Department of Chemical Pathology, Royal Brisbane and Women s Hospital, Herston, QLD, Australia
    Pathology 42:402-8. 2010
  4. ncbi Troponin revisited 2008: assay performance
    Jillian R Tate
    Department of Chemical Pathology, Pathology Queensland, Royal Brisbane and Women s Hospital, Herston, QLD, Australia
    Clin Chem Lab Med 46:1489-500. 2008
  5. ncbi Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases
    Jillian R Tate
    Chemical Pathology Department, Queensland Health Pathology Service, Royal Brisbane and Princess Alexandra Hospitals, Brisbane, Australia
    Clin Chim Acta 376:30-6. 2007
  6. ncbi Practical considerations for the measurement of free light chains in serum
    Jillian R Tate
    Chemical Pathology Department, Queensland Health Pathology Service, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia
    Clin Chem 49:1252-7. 2003
  7. ncbi The harmonization of cardiac troponin I measurement is independent of sample time collection but is dependent on the source of calibrator
    Jillian R Tate
    Department of Chemical Pathology, Queensland Health Pathology Service, Princess Alexandria Hospital, Woolloongabba, Queensland, Australia
    Clin Chim Acta 324:13-23. 2002
  8. ncbi Identification of an apolipoprotein(e) variant associated with type III hyperlipoproteinaemia in an indigenous Australian
    J R Tate
    Department of Chemical Pathology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Ann Clin Biochem 38:46-53. 2001
  9. ncbi First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay--Lp(a) SRM 2B
    Francesco Dati
    IVD Consulting, Marburg, Germany
    Clin Chem Lab Med 42:670-6. 2004
  10. ncbi Reporting of cardiac troponin concentrations
    Jillian R Tate
    Clin Chem 48:2077-80; author reply 2080-2. 2002

Detail Information

Publications10

  1. ncbi The determination of the 99th centile level for troponin assays in an Australian reference population
    Jillian R Tate
    Chemical Pathology Department, Pathology Queensland, Royal Brisbane and Women s Hospital, Herston, QLD 4029, Australia
    Ann Clin Biochem 45:275-88. 2008
    ..The 99th centile level for eight troponin assays was determined in an apparently cardio-healthy Australian reference population...
  2. ncbi Recommendations for standardized reporting of protein electrophoresis in Australia and New Zealand
    Jillian Tate
    Chemical Pathology Department, Pathology Queensland, Royal Brisbane and Women s Hospital, Herston Road, Brisbane, Queensland 4029, Australia
    Ann Clin Biochem 49:242-56. 2012
    ..The Australasian Association of Clinical Biochemists recognized a need to adopt a standardized approach to reporting SPEP and UPEP by clinical laboratories...
  3. ncbi Standardisation of cardiac troponin I measurement: past and present
    Jillian R Tate
    Pathology Queensland, Department of Chemical Pathology, Royal Brisbane and Women s Hospital, Herston, QLD, Australia
    Pathology 42:402-8. 2010
    ....
  4. ncbi Troponin revisited 2008: assay performance
    Jillian R Tate
    Department of Chemical Pathology, Pathology Queensland, Royal Brisbane and Women s Hospital, Herston, QLD, Australia
    Clin Chem Lab Med 46:1489-500. 2008
    ..Close collaboration between the laboratory and local clinicians is required to ensure adequate clinical validation of more sensitive cTn assays...
  5. ncbi Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases
    Jillian R Tate
    Chemical Pathology Department, Queensland Health Pathology Service, Royal Brisbane and Princess Alexandra Hospitals, Brisbane, Australia
    Clin Chim Acta 376:30-6. 2007
    ..We report on our experience with the assay during monitoring of light-chain myeloma (LCMM) and AL amyloidosis (AL)...
  6. ncbi Practical considerations for the measurement of free light chains in serum
    Jillian R Tate
    Chemical Pathology Department, Queensland Health Pathology Service, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia
    Clin Chem 49:1252-7. 2003
    ..We describe experience with and some potential pitfalls of the assay...
  7. ncbi The harmonization of cardiac troponin I measurement is independent of sample time collection but is dependent on the source of calibrator
    Jillian R Tate
    Department of Chemical Pathology, Queensland Health Pathology Service, Princess Alexandria Hospital, Woolloongabba, Queensland, Australia
    Clin Chim Acta 324:13-23. 2002
    ..We concluded that due to the heterogeneity of clinical samples, use of a pooled human serum material might better serve as a secondary reference reagent for cTnI measurement...
  8. ncbi Identification of an apolipoprotein(e) variant associated with type III hyperlipoproteinaemia in an indigenous Australian
    J R Tate
    Department of Chemical Pathology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    Ann Clin Biochem 38:46-53. 2001
    ....
  9. ncbi First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay--Lp(a) SRM 2B
    Francesco Dati
    IVD Consulting, Marburg, Germany
    Clin Chem Lab Med 42:670-6. 2004
    ....
  10. ncbi Reporting of cardiac troponin concentrations
    Jillian R Tate
    Clin Chem 48:2077-80; author reply 2080-2. 2002